133 related articles for article (PubMed ID: 36626943)
1. Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling.
Barber J; Al-Majdoub ZM; Couto N; Howard M; Elmorsi Y; Scotcher D; Alizai N; de Wildt S; Stader F; Sepp A; Rostami-Hodjegan A; Achour B
Eur J Pharm Sci; 2023 Mar; 182():106375. PubMed ID: 36626943
[TBL] [Abstract][Full Text] [Related]
2. Quantification of Neonatal Fc Receptor and Beta-2 Microglobulin in Human Liver Tissues by Ultraperformance Liquid Chromatography-Multiple Reaction Monitoring-based Targeted Quantitative Proteomics for Applications in Biotherapeutic Physiologically-based Pharmacokinetic Models.
Qiu X; Wang MZ
Drug Metab Dispos; 2020 Oct; 48(10):925-933. PubMed ID: 32723849
[TBL] [Abstract][Full Text] [Related]
3. FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review.
Fieux M; Le Quellec S; Bartier S; Coste A; Louis B; Giroudon C; Nourredine M; Bequignon E
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204226
[TBL] [Abstract][Full Text] [Related]
4. Human FcRn Tissue Expression Profile and Half-Life in PBMCs.
Fan YY; Farrokhi V; Caiazzo T; Wang M; O'Hara DM; Neubert H
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31443181
[TBL] [Abstract][Full Text] [Related]
5. The effect of the neonatal Fc receptor on human IgG biodistribution in mice.
Chen N; Wang W; Fauty S; Fang Y; Hamuro L; Hussain A; Prueksaritanont T
MAbs; 2014; 6(2):502-8. PubMed ID: 24492305
[TBL] [Abstract][Full Text] [Related]
6. Influence of FcRn binding properties on the gastrointestinal absorption and exposure profile of Fc molecules.
Lawrence SA; Blankenship R; Brown R; Estwick S; Ellis B; Thangaraju A; Datta-Mannan A
Bioorg Med Chem; 2021 Feb; 32():115942. PubMed ID: 33461147
[TBL] [Abstract][Full Text] [Related]
7. Humanized FcRn mouse models for evaluating pharmacokinetics of human IgG antibodies.
Proetzel G; Roopenian DC
Methods; 2014 Jan; 65(1):148-53. PubMed ID: 23867339
[TBL] [Abstract][Full Text] [Related]
8. Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics.
Piche-Nicholas NM; Avery LB; King AC; Kavosi M; Wang M; O'Hara DM; Tchistiakova L; Katragadda M
MAbs; 2018 Jan; 10(1):81-94. PubMed ID: 28991504
[TBL] [Abstract][Full Text] [Related]
9. Tissue expression profile of human neonatal Fc receptor (FcRn) in Tg32 transgenic mice.
Fan YY; Avery LB; Wang M; O'Hara DM; Leung S; Neubert H
MAbs; 2016 Jul; 8(5):848-53. PubMed ID: 27104806
[TBL] [Abstract][Full Text] [Related]
10. Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice.
Garg A; Balthasar JP
J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):687-709. PubMed ID: 17636457
[TBL] [Abstract][Full Text] [Related]
11. FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues.
Li T; Balthasar JP
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30326650
[TBL] [Abstract][Full Text] [Related]
12. Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human.
Shah DK; Betts AM
J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):67-86. PubMed ID: 22143261
[TBL] [Abstract][Full Text] [Related]
13. Distribution of rat neonatal Fc receptor in the principal organs of neonatal and pubertal rats.
Tian Z; Sutton BJ; Zhang X
J Recept Signal Transduct Res; 2014 Apr; 34(2):137-42. PubMed ID: 24303938
[TBL] [Abstract][Full Text] [Related]
14. Model-Based Assessment of the Contribution of Monocytes and Macrophages to the Pharmacokinetics of Monoclonal Antibodies.
Malik PRV; Hamadeh A; Edginton AN
Pharm Res; 2022 Feb; 39(2):239-250. PubMed ID: 35118567
[TBL] [Abstract][Full Text] [Related]
15. Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
Gurbaxani B; Dostalek M; Gardner I
Mol Immunol; 2013 Dec; 56(4):660-74. PubMed ID: 23917469
[TBL] [Abstract][Full Text] [Related]
16. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells.
Zhu X; Meng G; Dickinson BL; Li X; Mizoguchi E; Miao L; Wang Y; Robert C; Wu B; Smith PD; Lencer WI; Blumberg RS
J Immunol; 2001 Mar; 166(5):3266-76. PubMed ID: 11207281
[TBL] [Abstract][Full Text] [Related]
17. Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn
Mester S; Evers M; Meyer S; Nilsen J; Greiff V; Sandlie I; Leusen J; Andersen JT
MAbs; 2021; 13(1):1893888. PubMed ID: 33691596
[TBL] [Abstract][Full Text] [Related]
18. Generation of a double transgenic humanized neonatal Fc receptor (FcRn)/albumin mouse to study the pharmacokinetics of albumin-linked drugs.
Viuff D; Antunes F; Evans L; Cameron J; Dyrnesli H; Thue Ravn B; Stougaard M; Thiam K; Andersen B; Kjærulff S; Howard KA
J Control Release; 2016 Feb; 223():22-30. PubMed ID: 26699424
[TBL] [Abstract][Full Text] [Related]
19. Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.
Monnet C; Jorieux S; Souyris N; Zaki O; Jacquet A; Fournier N; Crozet F; de Romeuf C; Bouayadi K; Urbain R; Behrens CK; Mondon P; Fontayne A
MAbs; 2014; 6(2):422-36. PubMed ID: 24492301
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic models for FcRn-mediated IgG disposition.
Xiao JJ
J Biomed Biotechnol; 2012; 2012():282989. PubMed ID: 22665983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
